Trinity Biotech PLC

TRIB

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000888721

SEC filings (opens in a new tab)

No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Trinity Biotech PLC changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of TRIB: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	20	21	+1
Shares	7.29M	7.02M	−279.5K (−3.8%)
Value	$8.92M	$7.50M	−$1.43M (−16.0%)

New holders (2)

Institutions that held Trinity Biotech PLC at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to TRIB in Q3 2022
Institution	Shares	Value	% of portfolio
Virtu Financial LLC	14,625	$16.0K	0.00%
UBS Group AG	9,471	$10.0K	0.00%

Sold out (1)

Institutions that held Trinity Biotech PLC at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of TRIB in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Two Sigma Securities, LLC	11,049	$14.0K